A new study showed that fecal microbiota transplantation appeared to be safe and effective against Clostridioides difficile infection during a 2-year follow-up period. It was the top story in gastroenterology last week.
Another top story explored the use of pneumatic vs. sham dilation in patients with persistent dysphasia who underwent antireflux surgery.